Leap Therapeutics Inc logo

Leap Therapeutics Inc (LPTX) live share price

Leap Therapeutics Inc share price in USD $2.9 & INR ₹245.62

$2.9

-0.08

(-2.68%)

View live Leap Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Leap Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Leap Therapeutics Inc. Get details on the Indian mutual funds that are investing in Leap Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Leap Therapeutics Inc's financials.

Leap Therapeutics Inc share price movements

  • $2.86
    $3.06

    Day's Volatility :6.38%

  • $1.68
    $5.00

    52 Weeks Volatility :66.4%

Leap Therapeutics Inc Returns

PeriodLeap Therapeutics IncIndex (Russel 2000)
3 Months
4.2%
0.0%
6 Months
27.08%
0.0%
1 Year
12.88%
0.0%
3 Years
-87.58%
-19.8%

Leap Therapeutics Inc Key Statistics

in dollars & INR

Market Capitalization
$111.9M
Revenue TTM
$375.0K
EBITDA
$-64.7M
Earnings Per Share (EPS)
$-1.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-80.54%

How to invest in Leap Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Leap Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Leap Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Leap Therapeutics Inc or LPTX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Leap Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Leap Therapeutics Inc shares which would translate to 0.292 fractional shares of Leap Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Leap Therapeutics Inc

43%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Search volume for Leap Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 3, 2024. 43% more investors are searching Leap Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Leap Therapeutics Inc

  • Balyasny Asset Management LLC

    8.05%

  • Samsara BioCapital, LLC

    6.37%

  • 683 Capital Management LLC

    3.60%

  • Rock Springs Capital Management LP

    3.31%

  • Baker Bros Advisors LP

    3.06%

  • Simplify Asset Management Inc.

    2.76%

Analyst Recommendation on Leap Therapeutics Inc

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Leap Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Leap Therapeutics Inc

What analysts predicted

Upside of 292.24%

Current:

$2.90

Target:

$11.38

Insights on Leap Therapeutics Inc

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 20.2%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.4% return, outperforming this stock by 126.6%

Leap Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Leap Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Leap Therapeutics Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Leap Therapeutics Inc
-18.8%
27.08%
12.88%
-87.58%
-62.1%
Regeneron Pharmaceuticals, Inc.
-9.49%
-24.47%
-8.88%
20.04%
103.68%
Biontech Se
8.64%
19.01%
18.5%
-57.69%
426.41%
Alnylam Pharmaceuticals, Inc.
-6.25%
68.98%
46.39%
42.98%
103.71%
Vertex Pharmaceuticals Incorporated
-0.99%
-1.44%
33.51%
128.29%
109.86%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Leap Therapeutics Inc
NA
NA
0.75
-1.83
-0.81
-0.46
NA
2.35
Regeneron Pharmaceuticals, Inc.
18.55
18.66
1.12
44.91
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.22
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Leap Therapeutics Inc
Buy
$114.2M
-62.1%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
103.68%
18.55
33.61%
Biontech Se
Buy
$28.9B
426.41%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
103.71%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
109.86%
32.84
-4.51%

About Leap Therapeutics Inc

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.
Organization
Leap Therapeutics Inc
Employees
54
CEO
Mr. Douglas E. Onsi J.D.
Industry
Health Technology

Important FAQs about investing in Leap Therapeutics Inc from India :

What is Leap Therapeutics Inc share price today?

Leap Therapeutics Inc (LPTX) share price today is $2.90.

Can Indians buy Leap Therapeutics Inc shares?

Yes, Indians can invest in the Leap Therapeutics Inc (LPTX) from India.

With INDmoney, you can buy Leap Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Leap Therapeutics Inc at zero transaction cost.

How can I buy Leap Therapeutics Inc shares from India?

It is very easy to buy Leap Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Leap Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Leap Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Leap Therapeutics Inc stocks?

To start investing in Leap Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Leap Therapeutics Inc

Today’s highest price of Leap Therapeutics Inc (LPTX) is $3.06.

Today’s lowest price of Leap Therapeutics Inc (LPTX) is $2.86.

What is today's market capitalisation of Leap Therapeutics Inc

Today's market capitalisation of Leap Therapeutics Inc LPTX is 114.2M

What is the 52 Week High and Low Range of Leap Therapeutics Inc

  • 52 Week High

    $5.00

  • 52 Week Low

    $1.68

How much percentage Leap Therapeutics Inc is down from its 52 Week High?

Leap Therapeutics Inc (LPTX) share price is $2.90. It is down by 99% from its 52 Week High price of $5.00.

How much percentage Leap Therapeutics Inc is up from its 52 Week low?

Leap Therapeutics Inc (LPTX) share price is $2.90. It is up by 1% from its 52 Week Low price of $1.68.

What are the historical returns of Leap Therapeutics Inc?

  • 1 Month Returns

    -18.8%

  • 3 Months Returns

    27.08%

  • 1 Year Returns

    12.88%

  • 5 Years Returns

    -62.1%

Who is the Chief Executive Officer (CEO) of Leap Therapeutics Inc

Mr. Douglas E. Onsi J.D. is the current Chief Executive Officer (CEO) of Leap Therapeutics Inc.